☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Rheumatoid Arthritis
Fresenius Kabi Reports Results of MSB11456 (biosimilar- tocilizumab) in Two Clinical Trials for the Treatment of Rheumatoid Arthri...
September 7, 2021
Celltrion Launches Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis in Canada
June 7, 2021
Celltrion Presents One Year Results of Yuflyma (biosimilar- adalimumab) in P-III CT-P17 3.1 Trial for Rheumatoid Arthritis at EULA...
June 3, 2021
Biogen and Bio-Thera Report Results of BAT1806 (biosimilar- tocilizumab) in P-III Study for Moderate to Severe Rheumatoid Arthriti...
June 3, 2021
AbbVie Presents Results of Long-Term Efficacy and Safety Analyses for Rinvoq (upadacitinib) in P-III SELECT-COMPARE Study for Rheu...
June 2, 2021
Biogen Signs a License and Commercialization Agreement with Bio-Thera for BAT1806 (biosimilar- tocilizumab) to Treat Moderate to S...
April 9, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.